Senti Biosciences (SNTI) Change in Account Payables (2021 - 2025)
Senti Biosciences has reported Change in Account Payables over the past 5 years, most recently at $1.2 million for Q4 2025.
- For Q4 2025, Change in Account Payables fell 5.33% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.7 million, up 118.7%, while the annual FY2025 figure was $1.7 million, 118.7% up from the prior year.
- Change in Account Payables for Q4 2025 was $1.2 million at Senti Biosciences, up from $750000.0 in the prior quarter.
- Over five years, Change in Account Payables peaked at $1.2 million in Q4 2024 and troughed at -$2.3 million in Q4 2021.
- A 5-year average of $5381.3 and a median of $2299.0 in 2021 define the central range for Change in Account Payables.
- On a YoY basis, Change in Account Payables climbed as much as 8718.97% in 2022 and fell as far as 585814.29% in 2022.
- Year by year, Change in Account Payables stood at -$2.3 million in 2021, then skyrocketed by 103.99% to $93000.0 in 2022, then tumbled by 911.83% to -$755000.0 in 2023, then surged by 264.11% to $1.2 million in 2024, then fell by 5.33% to $1.2 million in 2025.
- Business Quant data shows Change in Account Payables for SNTI at $1.2 million in Q4 2025, $750000.0 in Q3 2025, and -$537000.0 in Q2 2025.